BIIB
Biogen Inc.$216.06-0.26% 1D· price as of Jun 30, 8:32 PM+70.23% over 1Y
Compare:BIIB
Mkt Cap
$31.9B
P/E
23.3×
Fwd P/E
13.0×
PEG
4.55
P/B
1.7×
P/S
3.2×
EV/EBITDA
9.7×
Beta
0.18
Div Yield
0.0%
Payout
0.0%
ROE
7.7%
Net Margin
13.8%
Short % Flt
3.5%
Inst. Own
96.3%
52-wk low $121.05$216.0652-wk high $219.72
+78.5% above low-1.7% from high
Seasonality — avg monthly return
Strongest Jun 6.3% · weakest Feb -4.2%Jan
+1.1
Feb
-4.2
Mar
-0.4
Apr
-0.9
May
+1.6
Jun
+6.3
Jul
-2.3
Aug
-1.4
Sep
+3.4
Oct
-1.5
Nov
+1.0
Dec
-1.0
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Biogen Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
BIIB — recent news
Loading headlines…
Quality scorecard
vs Biotechnology · 8 peers · percentile rank
40 / 100
Average
ROIC8.4%
14
ROE7.1%
29
Gross margin75.7%
43
Operating margin25.0%
29
FCF yield6.2%
100
Net debt / EBITDA1.4×
29
Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.